Screening and identification of specific markers for bladder transitional cell carcinoma from urine urothelial cells with suppressive subtractive hybridization and cDNA microarray

Journal of the Canadian Urological Association

Volumn 5, Issue 6, 2011, Pages

  Guo, Baihong ^a   Che, Tuanjie ^a   Shi, Baoguang ^b   Guo, Lijun ^b   Yin, Yongsheng ^b   Li, Lin ^a   Wang, Jinming ^a   Yan, Dongwen ^b   Chen, Yirong ^b  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054873411     PISSN: 19116470     EISSN: None     Source Type: Journal    
DOI: 10.5489/cuaj.09118     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Saad A, Hanbury DC, McNicholas TA, et al. The early detection and diagnosis of bladder cancer: A critical review of the options. Eur Urol 2001;39:619-633.
3. Sanchez-Carbayo M, Socci ND, Lozano J, et al. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006;24:778-789.
4. Van Le TS, Miller R, Barder T, et al. Highly specific urine-based marker of bladder cancer. Urology 2005;66:1256-1260.
5. Sauter G, Algaba F, Amin M, et al. WHO Classification of Tumour of urinary system and male genital organs. Lyon: IARCC Press; 2004.
6. Sobin DH, Witteking CH. TNM Classification of Malignant Tumour. New York, NY: Wiley-Liss; 2002:199-202.
7. Varanasi NL, Baskaran I, Alangaden GJ, et al. Novel effect of voriconazole on conidiation of Aspergillus species. Int J Antimicrob Agents 2004;23:72-79.
8. GenBank Overview. http://www.ncbi.nlm.nih.gov/genbank/. Accessed January 4, 2011.
9. Wall SJ, Edwards DR. Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, competitive, and real-time RT-PCRs. Anal Biochem 2002;300:269-273.
10. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008;3:1101-1108.
11. Bubner B, Baldwin IT. Use of real-time PCR for determining copy number and zygosity in transgenic plants. Plant Cell Rep 2004;23:263-271.
12. R package for statistical computing. http://www.r-project.org/. Accessed January 4, 2011.
13. Wild PJ, Herr A, Wissmann C, et al, Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 2005;11:4415-4429.
14. Blaveri E, Simko JP, Korkola JE, et al, Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005;11:4044-55.
15. Dyrskjøt L, Zieger K, Kruhøffer M, et al. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 2005;11:4029-4036.
16. Dyrskjøt L, Thykjaer T, Kruhøffer M, et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 2003;33:90-96.
17. Sanchez-Carbayo M, Socci ND, Lozano J, et al. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006;24:778-789.
18. Serel TA, Turan T, Soyupek S, et al. Urine and serum free IGF-1 levels in patients with bladder cancer: a brief report. Urol Res 2003;31:297-299.
19. Xie XY, Yang X, Zhang JH, et al. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR. Ann Clin Biochem 2007;44:523-528.
20. Scott V, Morgan EA, Stadler HS. Genitourinary functions of Hoxa13 and Hoxd13. J Biochem 2005;137:671-676.
21. Van Le TS, Myers J, Konety BR, et al. Functional characterization of the bladder cancer marker: BLCA-4. Clin Cancer Res 2004;10:1384-1391.
22. Tan SH, Bartsch D, Schwarz E, et al. Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Nacl Acad Sci USA 1998;85:121-125.
23. Bayani J, Squire JA. Application and interpretation of FISH in biomarker studies. Cancer Letters 2007;249:97-109.
24. Kipp BR, Tanasescu M, Else TA, et al. Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer. J Mol Diagn 2009;11:148-154.
25. Bubendorf L, Grilli B, Sauter G, et al. Multiprobe FISH for Enhanced Detection of Bladder Cancer in Voided Urine Specimens and Bladder Washings. Am J Clin Pathol 2001;116:79-86.
26. Serretta V, Lo Presti D, Vasile P, et al. Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients. Urology 1998;52:793-796.
27. Thomas L, Leyh H, Marberger M, et al. Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer. Clin Chem 1999;45:472-477.
28. Maruniak NA, Takezawa K, Murphy WM. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling. J Urol 2002;167:2404-2407.